Transradial Versus Transulnar Artery Approach for Coronary Interventions

NCT ID: NCT01364532

Last Updated: 2011-06-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE3

Total Enrollment

572 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-04-30

Study Completion Date

2011-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The transradial route is increasingly used as an access site in percutaneous coronary interventions, as it is considered equivalent to transfemoral approach in terms of efficacy but with a decreased vascular complication risk. Information concerning the efficacy and safety of transulnar approach is sparse. This is a prospective, randomized, investigator-initiated study to compare transradial versus transulnar approach as a default strategy for coronary angiography, ad-hoc or elective percutaneous coronary intervention (PCI). Consecutive eligible patients with an indication for coronary angiography, will be randomized after written informed consent in a 1:1 ratio to either transradial or transulnar access. Assessment of angiographic and procedural characteristics(including amount of contrast medium, arterial access, fluoroscopy and procedural time), as well as any vascular or other peri-procedural complications of the cases enrolled, will be performed. After hospital discharge, all patients will return at Day 60 ±5 days for Doppler ultrasound assessment of the forearm vessels and documentation of major adverse cardiovascular events (defined as death, myocardial infarction, target vessel revascularization and stroke. Coronary angiography patients will be additionally randomized in a 1:1 ratio to either 2500 or 5000 IU of unfractioned heparin.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arterial Access in Percutaneous Coronary Angiography or Intervention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Transulnar arterial access

Transulnar arterial access for coronary angiography, ad-hoc or elective PCI

Group Type EXPERIMENTAL

Transulnar arterial access

Intervention Type PROCEDURE

Transulnar arterial access in coronary angiography, ad-hoc or elective PCI

Transradial arterial access

Transradial arterial access for coronary angiography, ad-hoc or elective PCI

Group Type ACTIVE_COMPARATOR

Transradial arterial access

Intervention Type PROCEDURE

Transradial arterial access for coronary angiography,ad-hoc or elective PCI

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transulnar arterial access

Transulnar arterial access in coronary angiography, ad-hoc or elective PCI

Intervention Type PROCEDURE

Transradial arterial access

Transradial arterial access for coronary angiography,ad-hoc or elective PCI

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age\>18 years
* Plan for Coro- and ad hoc PCI, if necessary
* Written informed consent

Exclusion Criteria

* Cardiogenic shock, haemodynamic instability, Killip class III
* Chronic hemodialysis
* Coronary artery bypass grafting (CABG) with either bilateral internal mammary artery (IMA) or bilateral radial artery use
Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Patras

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Patras University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Patras University Hospital

Pátrai, Rion, Greece

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Greece

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

George Hahalis, MD

Role: primary

00306932751222

References

Explore related publications, articles, or registry entries linked to this study.

Hahalis G, Tsigkas G, Xanthopoulou I, Deftereos S, Ziakas A, Raisakis K, Pappas C, Sourgounis A, Grapsas N, Davlouros P, Galati A, Plakomyti TE, Mylona P, Styliadis I, Pyrgakis V, Alexopoulos D. Transulnar compared with transradial artery approach as a default strategy for coronary procedures: a randomized trial. The Transulnar or Transradial Instead of Coronary Transfemoral Angiographies Study (the AURA of ARTEMIS Study). Circ Cardiovasc Interv. 2013 Jun;6(3):252-61. doi: 10.1161/CIRCINTERVENTIONS.112.000150. Epub 2013 Jun 4.

Reference Type DERIVED
PMID: 23735472 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PATRASCARDIOLOGY-5

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.